Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Receivables (2019 - 2025)

Volitionrx filings provide 8 years of Receivables readings, the most recent being $309085.0 for Q3 2025.

  • On a quarterly basis, Receivables fell 1.13% to $309085.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $309085.0, a 1.13% decrease, with the full-year FY2024 number at $110574.0, down 54.42% from a year prior.
  • Receivables hit $309085.0 in Q3 2025 for Volitionrx, up from $189597.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $312611.0 in Q3 2024 to a low of $5492.0 in Q3 2022.
  • Median Receivables over the past 5 years was $110574.0 (2024), compared with a mean of $116984.4.
  • Biggest five-year swings in Receivables: skyrocketed 5783.47% in 2021 and later plummeted 71.93% in 2022.
  • Volitionrx's Receivables stood at $12510.0 in 2021, then soared by 480.41% to $72609.0 in 2022, then skyrocketed by 234.14% to $242617.0 in 2023, then plummeted by 54.42% to $110574.0 in 2024, then soared by 179.53% to $309085.0 in 2025.
  • The last three reported values for Receivables were $309085.0 (Q3 2025), $189597.0 (Q2 2025), and $187830.0 (Q1 2025) per Business Quant data.